TY  - GEN
AU  - Marks,William J
AU  - Ostrem,Jill L
AU  - Verhagen,Leonard
AU  - Starr,Philip A
AU  - Larson,Paul S
AU  - Bakay,Roy Ae
AU  - Taylor,Robin
AU  - Cahn-Weiner,Deborah A
AU  - Stoessl,A Jon
AU  - Olanow,C Warren
AU  - Bartus,Raymond T
TI  - Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
SN  - 1474-4422
PY  - 2008///0801
KW  - Adult
KW  - Aged
KW  - Dependovirus
KW  - physiology
KW  - Dose-Response Relationship, Drug
KW  - Drug Delivery Systems
KW  - Female
KW  - Genetic Therapy
KW  - methods
KW  - Genetic Vectors
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Motor Activity
KW  - drug effects
KW  - Neurturin
KW  - biosynthesis
KW  - Parkinson Disease
KW  - pathology
KW  - Putamen
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1474-4422(08)70065-6
ER  -